Bio & Pharma
CGBio inks export deal for hyaluronic acid fillers with Chinese distributor
The S.Korean bio company plans to expand the market share in China with regenerative medicine
By Mar 22, 2023 (Gmt+09:00)
1
Min read
Most Read
Alibaba eyes 1st investment in Korean e-commerce platform
Blackstone signs over $1 bn deal with MBK for 1st exit in Korea
NPS loses $1.2 bn in local stocks in Q1 on weak battery shares
OCI to invest up to $1.5 bn in Malaysia’s polysilicon plant
Korea's Lotte Insurance put on market for around $1.5 bn
CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distributor, for two types of hyaluronic acid (HA) fillers.
The announcement, made on Tuesday, reveals that CGBio will supply Giselleigne Universal and Giselleigne Signature 2, used for wrinkles on forehead, chin, nose, etc., to the Chinese partner for a total of 470 billion won ($359 million) over three years.
Shanghai Feiting Trading Co. has been the general agent for Giselleigne since 2019 and is a well-known medical device company in China.
“We plan to actively expand our market share in the Chinese HA filler market through this export contract,” said Yu Hyun-seung, CEO of CGBio.
Write to Yoorim Kim at youforest@hankyung.com
More to Read
-
Beauty & CosmeticsCG Bio opens cosmetic surgery clinic in Bali using bio-medical tech
Mar 14, 2023 (Gmt+09:00)
1 Min read
Comment 0
LOG IN